Hussain Joins Northwestern; Douillard Named ESMO CMO

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MAHA HUSSAIN will join the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as associate director for clinical sciences research, effective Sept. 1.

Hussain will also serve as co-director of the Lurie Cancer Center’s Genitourinary Oncology Program, along with Edward Schaeffer, chair of the Department of Urology at Northwestern University Feinberg School of Medicine. Hussain is currently Cis-Maisel Professor of Oncology, and professor of medicine and urology at the University of Michigan.

She has served in many scientific and leadership roles at the University of Michigan including associate director for clinical research and co-leader of the Prostate Cancer/GU Oncology Program at the UMComprehensive Cancer Center, as well as associate chief for clinical research in the Division of Hematology/Oncology.

Hussain’s research focuses on the development of therapeutics for prostate and bladder cancer. At Northwestern, Hussain will oversee the clinical sciences research programs and working groups, and foster interdisciplinary and inter-programmatic collaborations.

“We are thrilled to welcome Maha to the Lurie Cancer Center,” said Director Leonidas Platanias. “She is one of the world’s leading researchers in the field of prostate cancer and her presence will strengthen our clinical research efforts immensely.”

Hussain’s national scientific leadership roles include serving as co-chair of the Prostate Cancer Subcommittee/Genitourinary Cancer Committee of SWOG; as a member and chair of the integration panel of the U.S. Army Medical Research and Materiel Command Prostate Cancer Research Program; and as a member and chair of the FDA Oncology Drug Advisory Committee.

Hussain has held leadership roles within the American Society of Clinical Oncology and was recently elected to ASCO’s board of directors. She currently serves on ASCO’s Clinical Practice Guidelines Committee, as a member of the National Comprehensive Cancer Network International Committee and the Advanced Prostate Cancer Panel of the American Urological Association.

YOU MAY BE INTERESTED IN

Login